$22.86
-0.53-2.26%
At close: -
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
iShares Trust iShares Neuroscience and Healthcare ETF Stock Price, Quotes and Forecasts
IBRNARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
3.43M
Fund Score
iShares Trust iShares Neuroscience and Healthcare ETF Price, Quotes and Forecasts | ARCA:IBRN | Benzinga
Explore iShares Trust iShares Neuroscience and Healthcare ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IBRN.
| Open | $22.87 |
| High | $22.87 |
| 52 Wk High | $28.74 |
| AUM | 3.43M |
| Dividend | $0.11 |
| Ex-Div Date | Dec 17, 2024 |
| Volume | 213 |
| Market Cap | $3.68B |
| Mgmt Fee | 0.47% |
| P/E Ratio | 17.44 |
| Prev. Close | $23.39 |
| Low | $22.86 |
| 52 Wk Low | $17.86 |
| Shares Out | 150.00K |
| Yield | 0.47% |
| Div. Freq | S |
| Avg. Volume Daily | 1.45K |
| Beta | 0.71 |
| Avg. Expense Ratio | 0.47% |
| P/B Ratio | 2.31 |
Recent News
FAQ
Q
How do I buy iShares Trust iShares Neuroscience and Healthcare ETF (IBRN) stock?
A
You can purchase shares of iShares Trust iShares Neuroscience and Healthcare ETF (ARCA:IBRN) through any online brokerage.
Q
Who are iShares Trust iShares Neuroscience and Healthcare ETF (IBRN) competitors?
A
There are no as such competitors for iShares Trust iShares Neuroscience and Healthcare ETF.
Q
What is the forecast, or price target, for iShares Trust iShares Neuroscience and Healthcare ETF (IBRN) stock?
A
There is no analysis for iShares Trust iShares Neuroscience and Healthcare ETF to provide a consensus price target.
Q
What is the current price for iShares Trust iShares Neuroscience and Healthcare ETF (IBRN)?
A
The stock price for iShares Trust iShares Neuroscience and Healthcare ETF (ARCA: IBRN) is $23.79 last updated June 6, 2025 at 6:50 PM EDT.
Q
Does iShares Trust iShares Neuroscience and Healthcare ETF (IBRN) pay a dividend?
A
There are no upcoming dividends for iShares Trust iShares Neuroscience and Healthcare ETF.
Q
When is iShares Trust iShares Neuroscience and Healthcare ETF (ARCA:IBRN) reporting earnings?
A
iShares Trust iShares Neuroscience and Healthcare ETF does not have any upcoming earnings scheduled.
Q
Is iShares Trust iShares Neuroscience and Healthcare ETF (IBRN) going to split?
A
There is no upcoming split for iShares Trust iShares Neuroscience and Healthcare ETF.
| Open | $22.87 |
| High | $22.87 |
| 52 Wk High | $28.74 |
| AUM | 3.43M |
| Dividend | $0.11 |
| Ex-Div Date | Dec 17, 2024 |
| Volume | 213 |
| Market Cap | $3.68B |
| Mgmt Fee | 0.47% |
| P/E Ratio | 17.44 |
| Prev. Close | $23.39 |
| Low | $22.86 |
| 52 Wk Low | $17.86 |
| Shares Out | 150.00K |
| Yield | 0.47% |
| Div. Freq | S |
| Avg. Volume Daily | 1.45K |
| Beta | 0.71 |
| Avg. Expense Ratio | 0.47% |
| P/B Ratio | 2.31 |
About iShares Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | Aug 24, 2022 |
| Managers | Paul Whitehead Jennifer Hsui Greg Savage |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The Fund seeks to track the investment results of the NYSE FactSet Global Neuro Biopharma and MedTech Index (the Underlying Index), which measures the performance of equity securities of companies that are involved in the research, development or manufacturing of neurology biopharmaceuticals or neurological devices, as determined by ICE Data Indices, LLC, or its affiliates (the Index Provider or IDI).
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| DYN | Dyne Therapeutics Inc | 5.00% |
| AS | Argenx Se Ads | 4.51% |
| ACAD | Acadia Pharmaceuticals... | 5.74% |
| BHVN | Biohaven Pharmaceutica... | 4.22% |
| SRPT | Sarepta Therapeutics I... | 4.16% |
| ITCI | Intra-Cellular Therapi... | 4.40% |
| XENE | Xenon Pharmaceuticals ... | 4.73% |
| IE | Alkermes Plc | 4.16% |
| CERE | Cerevel Therapeutics H... | 4.05% |
| NBIX | Neurocrine Biosciences... | 5.08% |
| PTCT | Ptc Therapeutics Inc | 4.31% |
| KR | Sk Biopharmaceuticals ... | 4.26% |
| CPRX | Carver Bancorp Inc. | 5.31% |
| SRRK | Scholar Rock Holding C... | 3.76% |
| BIIB | Biogen Inc | 4.02% |
| DNLI | Denali Therapeutics In... | 4.51% |
| SUPN | Supernus Pharmaceutica... | 4.01% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved